Advertisement
Advertisement
IDXX
Idexx Laboratories Inc
546.49
USDSponsored
+0.70
+0.13%
May 19, 15:59 UTC -4
Closed
After-Market
546.60
+0.11
+0.02%
IDXX Earnings Reports
Positive Surprise Ratio
IDXX beat 39 of 41 last estimates.
95%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.22B
/$4.01
Implied change from Q1 26 (Revenue/ EPS)
+7.29%
/+15.56%
Implied change from Q2 25 (Revenue/ EPS)
+10.33%
/+10.47%
Idexx Laboratories Inc earnings per share and revenue
On May 05, 2026, IDXX reported earnings of 3.47 USD per share (EPS) for Q1 26, beating the estimate of 3.46 USD, resulting in a 0.10% surprise. Revenue reached 1.14 billion, compared to an expected 1.13 billion, with a 0.89% difference. The market reacted with a -0.03% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 11 analysts forecast an EPS of 4.01 USD, with revenue projected to reach 1.22 billion USD, implying an increase of 15.56% EPS, and increase of 7.29% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ClearPoint Neuro, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.27
Actual
-$0.32
Surprise
-14.78%
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.25
Actual
-$0.31
Surprise
-23.21%
QT Imaging Holdings, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.25
Surprise
-81.29%
Solana Company Class A Common Stock (DE)
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.48
Actual
-$1.03
Surprise
-110.38%
DarioHealth Corp. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$1.50
Actual
-$1.25
Surprise
+17.20%
SiNtx Technologies, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.67
Actual
-$0.70
Surprise
-3.98%
PAVmed Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.71
Actual
-$4.42
Surprise
-519.05%
Tenon Medical, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.28
Surprise
+6.78%
NexGel, Inc Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.11
Surprise
-54.06%
ENDRA Life Sciences Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$1.25
Actual
-$1.80
Surprise
-43.47%
FAQ
What were Idexx Laboratories Inc's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Idexx Laboratories Inc reported EPS of $3.47, missing estimates by 0.1%, and revenue of $1.14B, 0.89% above expectations.
How did the market react to Idexx Laboratories Inc's Q1 2026 earnings?
The stock price moved down -0.03%, changed from $563.12 before the earnings release to $562.97 the day after.
When is Idexx Laboratories Inc expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Idexx Laboratories Inc's next earnings report?
Based on 11
analysts, Idexx Laboratories Inc is expected to report EPS of $4.01 and revenue of $1.22B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement